Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines

Szyszka,Marta; Tyczewska,Marianna; Milecka,Paulina; Jopek,Karol; Celichowski,Piotr; Malendowicz,Ludwik K.; Rucinski,Marcin

doi:10.3892/or.2017.6066

Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines

Authors:
- Marta Szyszka
- Marianna Tyczewska
- Paulina Milecka
- Karol Jopek
- Piotr Celichowski
- Ludwik K. Malendowicz
- Marcin Rucinski
View Affiliations

Affiliations: Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland
Published online on: November 1, 2017 https://doi.org/10.3892/or.2017.6066
Pages: 182-192

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Results of studies on the expression of leptin and its receptors in the human prostate gland and human prostate cell lines are contradictory. Regarding this, we carefully reinvestigated this issue using human normal prostate (PrEC, PrSC, PrSMC) and prostate cancer (DU145, LNCaP, PC3) cell lines. Expression of leptin receptor isoforms was assessed by qPCR while the effects of leptin on cell proliferative activity was determined by real-time cell analyzer (RTCA). Expression of the leptin receptor variant 1 was not detected in LNCaP and PrSMC cell lines, but it was found in the remaining cell lines. In contrast, in all examined cell lines, isoforms 1-3 and 2 and 4 of the leptin receptor were found. The expression of isoforms 3 and 6 of the leptin receptor was observed in PC3, PrEC, PrSMC and PrSC cell lines, but not in LNCaP and DU145 cells. Expression of the leptin receptor isoforms 4-6 and 5 was not demonstrated in any of the tested cell lines. We also studied the effects of leptin on the expression of its receptor isoforms in all tested cell lines. At a wide range of concentrations, leptin did not change the expression of leptin receptor variant 1 in the DU145, PrEC and PC3 cell lines. In contrast, in the PrSC cell line, leptin significantly increased the expression of this gene. In all prostate cell lines tested, leptin did not alter the expression levels of variants 1-3 of the leptin receptor isoforms. Leptin did not alter the expression of isoforms 2 and 4 of the leptin receptor in the PC3 and LNCaP cell lines. In the DU145 and PrEC cell lines, leptin inhibited expression of these receptor isoforms while an opposite effect was noted in the PrSC cells. Leptin did not affect the expression level of variants 3 and 6 of its receptor in the PrEC and PC3 cell lines. However, in PrSMC cells, leptin inhibited the expression of variants 3 and 6 of its receptor, while in the PrSC cell line this cytokine significantly increased their expression levels. As assessed by RTCA, leptin stimulated the proliferative activity of DU145 cells, but inhibited this activity in LNCaP cells. At all concentrations tested, leptin did not change the proliferation rate of the PC3, PrEC and PrSMC cells. In contrast, leptin notably stimulated the proliferative activity of the PrSC (prostate stromal cell) cell line. Thus, our study demonstrated that in all tested human normal prostate and prostate cancer cell lines, transcription variants 4, 5 and 6 of the leptin receptor were not expressed. Leptin receptor transcription variants 1, 2 and 3 showed differential expression, which was present in the PC3, PrEC and PrSC cell lines. Our data also suggest that the stimulatory effects of leptin on proliferative activity of the studied cell lines require the expression of leptin receptor variant 1 in the affected cells.

View Figures

View References

1	Bergström A, Pisani P, Tenet V, Wolk A and Adami HO: Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 91:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
2	Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J and Stanczyk FZ: Prostate cancer risk and serum levels of insulin and leptin: A population-based study. J Natl Cancer Inst. 93:783–789. 2001. View Article : Google Scholar : PubMed/NCBI
3	Bray GA: The underlying basis for obesity: Relationship to cancer. J Nutr. 132 Suppl:S3451–S3455. 2002.
4	Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
5	Allott EH, Masko EM and Freedland SJ: Obesity and prostate cancer: Weighing the evidence. Eur Urol. 63:800–809. 2013. View Article : Google Scholar : PubMed/NCBI
6	Hoda MR, Mohammed N, Theil G, Fischer K and Fornara P: Obesity and prostate cancer. Role of adipocytokines and clinical implications. Urologe A. 51:1253–1260. 2012.(In German).
7	Hoda MR, Theil G, Mohammed N, Fischer K and Fornara P: The adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancer. J Oncol. 2012:2803862012. View Article : Google Scholar : PubMed/NCBI
8	Cao Y and Giovannucci E: Obesity and prostate cancer. Recent Results Cancer Res. 208:137–153. 2016. View Article : Google Scholar : PubMed/NCBI
9	Patel SB, Reams GP, Spear RM, Freeman RH and Villarreal D: Leptin: Linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep. 10:131–137. 2008. View Article : Google Scholar : PubMed/NCBI
10	Kaur J: A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014:9431622014. View Article : Google Scholar : PubMed/NCBI
11	Mantzoros CS: The role of leptin in human obesity and disease: A review of current evidence. Ann Intern Med. 130:671–680. 1999. View Article : Google Scholar : PubMed/NCBI
12	Klok MD, Jakobsdottir S and Drent ML: The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review. Obes Rev. 8:21–34. 2007. View Article : Google Scholar : PubMed/NCBI
13	Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
14	Cummings DE and Foster KE: Ghrelin-leptin tango in body-weight regulation. Gastroenterology. 124:1532–1535. 2003. View Article : Google Scholar : PubMed/NCBI
15	Konturek PC, Konturek JW, Cześnikiewicz-Guzik M, Brzozowski T, Sito E and Konturek SJ: Neuro-hormonal control of foodintake: Basic mechanisms and clinical implications. J Physiol Pharmacol. 56 Suppl 6:5–25. 2005.
16	Perry B and Wang Y: Appetite regulation and weight control: The role of gut hormones. Nutr Diabetes. 2:e262012. View Article : Google Scholar : PubMed/NCBI
17	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
18	Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155–1161. 1995. View Article : Google Scholar : PubMed/NCBI
19	Friedman JM and Halaas JL: Leptin and the regulation of body weight in mammals. Nature. 395:763–770. 1998. View Article : Google Scholar : PubMed/NCBI
20	Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al: Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1263–1271. 1995. View Article : Google Scholar : PubMed/NCBI
21	Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D and Snodgrass HR: Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nat Med. 2:585–589. 1996. View Article : Google Scholar : PubMed/NCBI
22	Ahima RS and Flier JS: Leptin. Annu Rev Physiol. 62:413–437. 2000. View Article : Google Scholar : PubMed/NCBI
23	Malendowicz W, Rucinski M, Macchi C, Spinazzi R, Ziolkowska A, Nussdorfer GG and Kwias Z: Leptin and leptin receptors in the prostate and seminal vesicles of the adult rat. Int J Mol Med. 18:615–618. 2006.PubMed/NCBI
24	Maamra M, Bidlingmaier M, Postel-Vinay MC, Wu Z, Strasburger CJ and Ross RJ: Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology. 142:4389–4393. 2001. View Article : Google Scholar : PubMed/NCBI
25	Ge H, Huang L, Pourbahrami T and Li C: Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem. 277:45898–45903. 2002. View Article : Google Scholar : PubMed/NCBI
26	Schultz SC and Widmaier EP: Leptin receptorsLeptin. Castracane VD and Henson MC: 25. Springer; Endocrine Updates, Heidelberg: pp. 11–31. 2007, View Article : Google Scholar
27	Wada N, Hirako S, Takenoya F, Kageyama H, Okabe M and Shioda S: Leptin and its receptors. J Chem Neuroanat 61–62. 191–199. 2014. View Article : Google Scholar
28	Stattin P, Söderberg S, Hallmans G, Bylund A, Kaaks R, Stenman UH, Bergh A and Olsson T: Leptin is associated with increased prostate cancer risk: A nested case-referent study. J Clin Endocrinol Metab. 86:1341–1345. 2001. View Article : Google Scholar : PubMed/NCBI
29	Malendowicz W and Kwias Z: Leptin receptor isoforms in benign prostatic hyperplasia (BPH). BPH and prostate cancer - no association between plasma concentrations of leptin and prostate specific antigen (PSA). Cent European J Urol. 62:96–100. 2009. View Article : Google Scholar
30	Onuma M, Bub JD, Rummel TL and Iwamoto Y: Prostate cancer cell-adipocyte interaction: Leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 278:42660–42667. 2003. View Article : Google Scholar : PubMed/NCBI
31	Somasundar P, Frankenberry KA, Skinner H, Vedula G, McFadden DW, Riggs D, Jackson B, Vangilder R, Hileman SM and Vona-Davis LC: Prostate cancer cell proliferation is influenced by leptin. J Surg Res. 118:71–82. 2004. View Article : Google Scholar : PubMed/NCBI
32	Paschke L, Rucinski M, Ziolkowska A, Zemleduch T, Malendowicz W, Kwias Z and Malendowicz LK: ZFP91 - a newly described gene potentially involved in prostate pathology. Pathol Oncol Res. 20:453–459. 2014. View Article : Google Scholar : PubMed/NCBI
33	Szyszka M, Paschke L, Tyczewska M, Rucinski M, Grabowska P and Malendowicz LK: Lack of expression of preproorexin and orexin receptors genes in human normal and prostate cancer cell lines. Folia Histochem Cytobiol. 53:333–341. 2015. View Article : Google Scholar : PubMed/NCBI
34	Rucinski M, Albertin G, Spinazzi R, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Cerebellin in the rat adrenal gland: Gene expression and effects of CER and (des-Ser1)CER on the secretion and growth of cultured adrenocortical cells. Int J Mol Med. 15:411–415. 2005.PubMed/NCBI
35	Rucinski M, Ziolkowska A, Tyczewska M and Malendowicz LK: Expression of prepro-ghrelin and related receptor genes in the rat adrenal gland and evidences that ghrelin exerts a potent stimulating effect on corticosterone secretion by cultured rat adrenocortical cells. Peptides. 30:1448–1455. 2009. View Article : Google Scholar : PubMed/NCBI
36	Tyczewska M, Rucinski M, Ziolkowska A, Szyszka M, Trejter M, Hochol-Molenda A, Nowak KW and Malendowicz LK: Enucleation-induced rat adrenal gland regeneration: Expression profile of selected genes involved in control of adrenocortical cell proliferation. Int J Endocrinol. 2014:1303592014. View Article : Google Scholar : PubMed/NCBI
37	Markowska A, Belloni AS, Rucinski M, Parenti AR, Nardelli GB, Drews K, Nussdorfer GG and Malendowicz LK: Leptin and leptin receptor expression in the myometrium and uterine myomas: Is leptin involved in tumor development? Int J Oncol. 27:1505–1509. 2005.PubMed/NCBI
38	Noda T, Kikugawa T, Tanji N, Miura N, Asai S, Higashiyama S and Yokoyama M: Long-term exposure to leptin enhances the growth of prostate cancer cells. Int J Oncol. 46:1535–1542. 2015. View Article : Google Scholar : PubMed/NCBI
39	Somasundar P, Yu AK, Vona-Davis L and McFadden DW: Differential effects of leptin on cancer in vitro. J Surg Res. 113:50–55. 2003. View Article : Google Scholar : PubMed/NCBI
40	Bub JD, Miyazaki T and Iwamoto Y: Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun. 340:1158–1166. 2006. View Article : Google Scholar : PubMed/NCBI